Skip to main content
. Author manuscript; available in PMC: 2016 Aug 1.
Published in final edited form as: J Pediatr. 2015 May 23;167(2):409–415. doi: 10.1016/j.jpeds.2015.04.066

Table 4. Diagnostic imaging results of patients with mediastinal masses, according to final diagnosis.

Overall (N=117) Benign (N=93) Malignant (N=24) Unadjusted OR (95% CI) P
Anterior mediastinal mass 24 (21) 4 (4) 20 (74) 0.02 (0.00-0.06) <0.001
Anterior mediastinal involvement only 4 (3) 1 (1) 3 (11) 0.08 (0.01-0.84) 0.04
Middle mediastinal mass 111 (95) 87 (97) 24 (89) 3.63 (0.69-19.12) 0.13
Middle mediastinal involvement only 86 (69) 80 (82) 6 (22) 16.47 (5.78-46.95) <0.001
Posterior mediastinal mass 6 (5) 3 (3) 3 (11) 0.28 (0.05-1.46) 0.13
Posterior mediastinal involvement only 2 (2) 2 (2) 0 (0) 1.00
Pulmonary nodules 62 (53) 57 (63) 5 (19) 7.60 (2.63-21.97) <0.001
Any parenchymal disease (including pulmonary nodules) 71 (61) 62 (69) 9 (33) 4.43 (1.77-11.07) 0.001
Cervical adenopathy 12 (10) 1 (1) 11 (41) 0.02 (0.00-0.14) <0.001
Supraclavicular adenopathy 14 (12) 3 (3) 11 (41) 0.05 (0.01-0.20) <0.001
Axillary adenopathy 9 (8) 3 (3) 6 (22) 0.12 (0.03-0.52) 0.005
Any extrathoracic adenopathy 23 (20) 6 (7) 17 (63) 0.04 (0.01-0.13) <0.001
Retroperitoneal adenopathy 6 (5) 0 (0) 6 (22) 0 <0.001
Splenic involvement 4 (3) 4 (4) 0 (0) 0.57
Intraabdominal involvement 10 (9) 4 (4) 6 (22) 0.16 (0.04-0.63) 0.009
Pleural effusion 17 (15) 6 (7) 11 (41) 0.10 (0.03-0.32) <0.001
Pericardial effusion 11 (9) 9 (10) 2 (7) 1.39 (0.28-6.85) 0.69
Calcified pulmonary nodules 10 (9) 8 (9) 2 (7) 1.21 (0.24-6.12) 0.81
Calcified mediastinal adenopathy 27 (23) 24 (27) 3 (11) 2.91 (0.80-10.55) 0.10

Data are presented as No. (%).